James W. Scholey

10.8k total citations · 1 hit paper
135 papers, 8.3k citations indexed

About

James W. Scholey is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Molecular Biology. According to data from OpenAlex, James W. Scholey has authored 135 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cardiology and Cardiovascular Medicine, 45 papers in Nephrology and 36 papers in Molecular Biology. Recurrent topics in James W. Scholey's work include Renin-Angiotensin System Studies (36 papers), Chronic Kidney Disease and Diabetes (35 papers) and Hormonal Regulation and Hypertension (26 papers). James W. Scholey is often cited by papers focused on Renin-Angiotensin System Studies (36 papers), Chronic Kidney Disease and Diabetes (35 papers) and Hormonal Regulation and Hypertension (26 papers). James W. Scholey collaborates with scholars based in Canada, United States and Austria. James W. Scholey's co-authors include Heather N. Reich, Judith Miller, Gavin Y. Oudit, Josef Penninger, Kerri Thai, Andrew M. Herzenberg, Hao Ly, David Z.I. Cherney, Daniel C. Cattran and Daniel Cattran and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

James W. Scholey

135 papers receiving 8.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiotensin-converting enzyme 2 is an essential regulator of heart function

2002 1.3k citations Michael A. Crackower, Renu Sarao et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James W. Scholey Canada	46	3.0k	2.3k	2.2k	2.1k	866	135	8.3k
Kevin D. Burns Canada	42	2.4k 0.8×	1.3k 0.6×	1.7k 0.8×	2.0k 1.0×	558 0.6×	160	6.0k
Donald E. Kohan United States	52	3.3k 1.1×	1.9k 0.8×	2.6k 1.2×	4.2k 2.0×	562 0.6×	227	10.7k
Paola Fioretto Italy	53	1.9k 0.7×	4.5k 1.9×	4.1k 1.8×	1.9k 0.9×	611 0.7×	201	10.2k
Günter Wolf Germany	52	1.9k 0.6×	3.7k 1.6×	2.3k 1.0×	3.5k 1.7×	669 0.8×	359	12.3k
Berthold Hocher Germany	53	2.0k 0.7×	1.7k 0.7×	1.6k 0.7×	2.2k 1.0×	272 0.3×	355	9.4k
Carla Zoja Italy	69	2.4k 0.8×	4.8k 2.1×	1.3k 0.6×	3.4k 1.6×	583 0.7×	192	13.3k
Steven D. Crowley United States	42	1.9k 0.6×	999 0.4×	1.3k 0.6×	2.1k 1.0×	393 0.5×	109	6.0k
Takeshi Sugaya Japan	61	2.9k 1.0×	3.4k 1.5×	1.8k 0.8×	3.7k 1.8×	929 1.1×	229	10.7k
Óscar Lorenzo Spain	42	2.3k 0.8×	677 0.3×	1.2k 0.5×	2.4k 1.1×	459 0.5×	110	6.3k
Reiko Inagi Japan	58	660 0.2×	2.7k 1.2×	1.2k 0.6×	2.9k 1.4×	632 0.7×	194	10.1k

Countries citing papers authored by James W. Scholey

Since Specialization

Citations

This map shows the geographic impact of James W. Scholey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James W. Scholey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James W. Scholey more than expected).

Fields of papers citing papers by James W. Scholey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James W. Scholey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James W. Scholey. The network helps show where James W. Scholey may publish in the future.

Co-authorship network of co-authors of James W. Scholey

This figure shows the co-authorship network connecting the top 25 collaborators of James W. Scholey. A scholar is included among the top collaborators of James W. Scholey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James W. Scholey. James W. Scholey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sullivan, Katie, Rahim Moineddin, Farid H. Mahmud, et al.. (2022). Urinary interleukin-9 in youth with type 1 diabetes mellitus. Acta Diabetologica. 59(7). 939–947. 7 indexed citations

Fine, Noah, Joyce Zhou, Rohan John, et al.. (2020). Inhibition of BRD4 Reduces Neutrophil Activation and Adhesion to the Vascular Endothelium Following Ischemia Reperfusion Injury. International Journal of Molecular Sciences. 21(24). 9620–9620. 12 indexed citations

Sullivan, Katie, James W. Scholey, Rahim Moineddin, et al.. (2020). Urinary podocyte-derived microparticles in youth with type 1 and type 2 diabetes. Diabetologia. 64(2). 469–475. 15 indexed citations

Shikatani, Eric A., Rickvinder Besla, Andrew Levy, et al.. (2019). B-Cell Deficiency Lowers Blood Pressure in Mice. Hypertension. 73(3). 561–570. 27 indexed citations

Almaani, Salem, Stephenie D. Prokopec, Jianying Zhang, et al.. (2019). Rethinking Lupus Nephritis Classification on a Molecular Level. Journal of Clinical Medicine. 8(10). 1524–1524. 23 indexed citations

Van, Julie A.D., Sergi Clotet‐Freixas, Joyce Zhou, et al.. (2019). Peptidomic Analysis of Urine from Youths with Early Type 1 Diabetes Reveals Novel Bioactivity of Uromodulin Peptides In Vitro. Molecular & Cellular Proteomics. 19(3). 501–517. 28 indexed citations

Konvalinka, Ana, Joyce Zhou, Apostolos Dimitromanolakis, et al.. (2013). Determination of an Angiotensin II-regulated Proteome in Primary Human Kidney Cells by Stable Isotope Labeling of Amino Acids in Cell Culture (SILAC). Journal of Biological Chemistry. 288(34). 24834–24847. 29 indexed citations

Cherney, David Z.I., Heather N. Reich, James W. Scholey, et al.. (2013). The effect of aliskiren on urinary cytokine/chemokine responses to clamped hyperglycaemia in type 1 diabetes. Diabetologia. 56(10). 2308–2317. 13 indexed citations

Bodiga, Sreedhar, Wang Wang, Ratnadeep Basu, et al.. (2011). Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47phox NADPH oxidase subunit. Cardiovascular Research. 91(1). 151–161. 72 indexed citations

10.

Oudit, Gavin Y., George C. Liu, Jiuchang Zhong, et al.. (2009). Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy. Diabetes. 59(2). 529–538. 249 indexed citations

11.

Cherney, David Z.I., Judith Miller, James W. Scholey, et al.. (2007). The Effect of Cyclooxygenase-2 Inhibition on Renal Hemodynamic Function in Humans With Type 1 Diabetes. Diabetes. 57(3). 688–695. 75 indexed citations

12.

Oudit, Gavin Y., Heather N. Reich, Zamaneh Kassiri, et al.. (2007). Loss of Angiotensin-Converting Enzyme-2 (Ace2) Accelerates Diabetic Kidney Injury. American Journal Of Pathology. 171(2). 438–451. 215 indexed citations

13.

Krepinsky, Joan C., Yanxia Li, Lieqi Liu, et al.. (2005). Akt Mediates Mechanical Strain-Induced Collagen Production by Mesangial Cells. Journal of the American Society of Nephrology. 16(6). 1661–1672. 42 indexed citations

14.

Page, Andrea, Heather N. Reich, Joyce Zhou, et al.. (2005). Endothelial Nitric Oxide Synthase Gene/Gender Interactions and the Renal Hemodynamic Response to Angiotensin II. Journal of the American Society of Nephrology. 16(10). 3053–3060. 19 indexed citations

15.

Needham, Dale M., et al.. (2004). Troponin I and T levels in renal failure patients without acute coronary syndrome: a systematic review of the literature.. PubMed. 20(12). 1212–8. 49 indexed citations

16.

Krepinsky, Joan C., Dongcheng Wu, Alistair J. Ingram, James W. Scholey, & Damu Tang. (2002). Developments in mitogen-induced extracellular kinase 1 inhibitors and their use in the treatment of disease. Expert Opinion on Therapeutic Patents. 12(12). 1795–1811. 8 indexed citations

17.

Crackower, Michael A., Renu Sarao, Gavin Y. Oudit, et al.. (2002). Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 417(6891). 822–828. 1340 indexed citations breakdown →

18.

Duncan, John A., James W. Scholey, & Judith Miller. (2001). Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes. Current Opinion in Nephrology & Hypertension. 10(1). 111–116. 68 indexed citations

19.

Ingram, Alistair J., Hao Ly, Kerri Thai, Myung Hee Kang, & James W. Scholey. (1999). Activation of mesangial cell signaling cascades in response to mechanical strain. Kidney International. 55(2). 476–485. 63 indexed citations

20.

Mills, David E., et al.. (1992). ATTENUATION OF CYCLOSPORINE-INDUCED HYPERTENSION BY DIETARY FATTY ACIDS IN THE BORDERLINE HYPERTENSIVE RAT. Transplantation. 53(3). 649–654. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact